Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802360 · ClinicalTrials.gov registry record · Phase 4
MENOPUR® Versus FOLLISTIM®
A Phase 4 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 173
- Enrollment target
NCT00802360: Completed Phase 4 study, sponsored by Ferring Pharmaceuticals.
NCT00802360 is a Phase 4 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 173 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00802360, a Phase 4 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 173 participants
- Enrollment target
Study Summary
To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles
Primary Outcome
The ongoing pregnancy was defined as a positive fetal heart movement (motion) at approximately six weeks of gestation and confirmed in a follow-up pregnancy ultrasound.
Interventions
- DRUG Ganirelix
- DRUG Menotropin
- DRUG Progesterone in oil
- DRUG Progestrone vaginal insert
- DRUG follitropin beta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
What the finished NCT00802360 record still lists
NCT00802360 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 5 interventions - of which Ganirelix is the first listed.
NCT00802360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00802360 about?
NCT00802360 is a clinical study titled "MENOPUR® Versus FOLLISTIM®". To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles
What is the current status of trial NCT00802360?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 173 participants. The study started on 2008-12. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00802360?
The interventions under investigation include: Ganirelix (DRUG), Menotropin (DRUG), Progesterone in oil (DRUG), Progestrone vaginal insert (DRUG), follitropin beta (DRUG).
Who is sponsoring clinical trial NCT00802360?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00802360's enrollment target sits among peer trials
173 481st of 2000 higher than 1,520 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia